Since the combination treatment of mABL001 with irinotecan showed more potent anti-cancer effects on tumor progression and anti-angiogenic effects on tumor vessels, the effects of the combination therapy on tumor cells were analyzed by immunohistochemical staining for activated caspase-3, an apoptotic cell marker. The gene discussed is CASP3; the disease is neoplasm.